Cardiol Therapeutics Inc. Class ACRDL

13F holders, Q1 2025 (March 31)
38holders −5
4new positions
9sold out
$0.96avg. 13F price*

At the end of Q1 2025, 38 institutions reported holding Cardiol Therapeutics Inc. Class A (CRDL) in their 13F filings, down 5 from Q4 2024. 4 opened new positions and 9 sold out. The largest holders were Tejara Capital Ltd ($3.1M), AdvisorShares Investments LLC ($911K) and MMCAP International Inc. SPC ($759K).

Company
Cardiol Therapeutics Inc. Class A
CUSIP
14161Y200
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2024: 35Q1 2024Q2 2024: 41Q2 2024Q3 2024: 41Q3 2024Q4 2024: 43Q4 2024Q1 2025: 38Q1 2025Q2 2025: 38Q2 2025Q3 2025: 48Q3 2025Q4 2025: 41Q4 2025Q1 2026: 47Q1 2026Q2 2026: 52Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions4$63K
Exits9$130K

All 13F filers, Q4 2024 → Q1 2025: 591,617 shares bought and 365,317 shares sold, net +226,300 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 38 holders

Tejara Capital Ltd 1.53% Add +2.5% 3,194,990 $3.1M
AdvisorShares Investments LLC 0.18% Add +11.3% 982,488 $911K
MMCAP International Inc. SPC 0.13% Reduce -1.6% 782,625 $759K
UBS Group AG 0.00% Add +112.0% 497,857 $483K
PVG Asset Management Corp. 1.85% Reduce -10.3% 437,362 $424K
Lion Street Advisors, LLC 0.10% Add +8.5% 333,725 $318K
Envestnet Asset Management Inc. 0.00% Add +6.3% 329,149 $315K
Cambridge Investment Research Advisors, Inc. 0.00% Reduce -2.8% 321,285 $310K
Atria Investments, Inc 0.00% Add +2.3% 139,053 $135K
Mgo One Seven LLC 0.00% No change 100,000 $97K
Knoll Capital Management, LLC 0.06% No change 100,000 $97K
Cetera Investment Advisers 0.00% Add +55.1% 67,564 $65K
Morgan Stanley 0.00% Reduce -70.9% 59,613 $58K
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.00% New 55,000 $53K
Geode Capital Management, LLC 0.00% No change 52,435 $51K
Bank of Montreal 0.00% Add +0.2% 50,079 $48K
Goldman Sachs Group Inc. 0.00% Add +9.2% 39,200 $38K
Marble Harbor Investment Counsel, LLC 0.00% No change 36,900 $36K
Jones Financial Companies LLLP 0.00% Add +6.1% 21,060 $20K
Virtu Financial LLC 0.00% Reduce -66.6% 16,038 $16K
Wealthspire Advisors, LLC 0.00% No change 15,151 $15K
Royal Bank of Canada 0.00% Reduce -48.3% 12,814 $12K
Bank of America Corp. 0.00% Reduce -2.6% 11,200 $11K
Piscataqua Savings Bank 0.01% No change 5,000 $10K
Independent Advisor Alliance 0.00% New 10,000 $10K
Evelyn Partners Investment Management LLP 0.00% No change 10,000 $10K
Group One Trading LLC 0.00% Add +59.1% 8,446 $8K
National Bank of Canada 0.00% Add +45.5% 8,563 $8K
TD Waterhouse Canada Inc. 0.00% No change 6,900 $6K
Osaic Holdings, Inc. 0.00% Add +14.6% 4,289 $4K
Valley National Advisers Inc. 0.00% No change 5,000 $4K
Hartford Financial Management Inc. 0.00% No change 4,000 $4K
SouthState Bank Corp 0.00% No change 1,000 $970
SBI Securities Co., Ltd. 0.00% Add +72.7% 475 $461
Painted Porch Advisors LLC 0.00% Reduce -70.6% 147 $143
Tower Research Capital LLC (TRC) 0.00% New 118 $114
Stone House Investment Management, LLC 0.00% New 50 $48
Wells Fargo & Company 0.00% Reduce -98.8% 25 $24

"% of holder's portfolio" is CRDL's weight in each manager's 13F, not the share of Cardiol Therapeutics Inc. Class A the manager owns.